EnVVeno Medical Operating Expenses 2017-2024 | NVNO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

EnVVeno Medical operating expenses from 2017 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

EnVVeno Medical operating expenses from 2017 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$216.7B
Thermo Fisher Scientific (TMO)	$203.1B
Alcon (ALC)	$44.2B
Edwards Lifesciences (EW)	$44B
IDEXX Laboratories (IDXX)	$36.9B
DexCom (DXCM)	$35B
IQVIA Holdings (IQV)	$34.6B
Mettler-Toledo (MTD)	$27.3B
Waters (WAT)	$22.4B
STERIS (STE)	$21.8B
SONOVA HOLDING (SONVY)	$19.6B
Hologic (HOLX)	$14.4B
Fresenius Medical Care AG KGaA (FMS)	$13.6B
Penumbra (PEN)	$11.7B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$11.5B
Masimo (MASI)	$9.6B
Glaukos (GKOS)	$8.9B
Teleflex (TFX)	$8.1B
Integer Holdings (ITGR)	$4.8B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$3.5B
Veracyte (VCYT)	$3.3B
Nihon Kohden (NHNKY)	$2.7B
TransMedics (TMDX)	$2.7B
LivaNova (LIVN)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
Alphatec Holdings (ATEC)	$1.5B